Under the study, Amgen and Allergan evaluated the efficacy and safety of ABP 215 compared with Genentech’s Avastin (bevacizumab) in patients with advanced non-small cell lung cancer. The
The company started enrolling patients in IFN-K-002 double-blind, randomized, placebo-controlled, multi-center study to identify the biological and clinical efficacy of IFNa-Kinoid in patients suffering from SLE. Neovacs intends
Edoxaban is an oral, once-daily, direct factor Xa inhibitor, which is one of the key parts responsible for blood clotting. Under the ENGAGE AF-TIMI 48 global phase 3
Pfizer secured a license for the contraceptive, allowing women to inject themselves at home rather than going to clinic or GP surgery. Sayana Press combines a long-acting, reversible,
The company said the drug is better than a placebo in reducing pain in patients undergoing bunionectomy. The company carried out the randomized, placebo-controlled, double-blind study in 64
The company carried out the worldwide Phase III RECOURSE trial in 800 patients who were earlier treated for mCRC. It met the primary efficacy endpoint of statistically significant
The US Food and Drug Administration (FDA) has approved Perrigo’s generic version of Valeant Pharmaceuticals’ BenzaClin Topical Gel. The commercial launch will start immediately. The FDA concluded that
Novo Nordisk Iran and the Food and Drug Administration of the Islamic Republic of Iran have signed a Memorandum of Understanding for the project, which is expected to
Gerilimzumab is directed against the IL-6 cytokine. The double-blinded and placebo controlled trial includes single and multiple ascending dose cohorts. RuiYi plans to release the trial’s results in
The druggability of two kinase targets in a specific genetic context is being validated by the two companies as part of the original alliance started in September 2013.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.